Biogen Idec and Sobi to Donate 1 Billion International Units of Clotting Factor to Support Treatment of Hemophilia in Developing World

[Business Wire] – Biogen Idec and Swedish Orphan Biovitrum AB today announced their intent to produce one billion international units of clotting factor therapy for humanitarian aid programs in the developing world at the World Federation of Hemophilia 2 more

View todays social media effects on BIIB

View the latest stocks trending across Twitter. Click to view dashboard

See who Biogen is hiring next, click here to view